Kenya Recalls JJ Childrens Cough Syrup Over Suspected Toxicity
Thu, 11 Apr 2024 09:00
Kenya's drug regulator is recalling a batch of Johnson & Johnson (JNJ.N) children's cough syrup, it said on Thursday, a day after Nigeria recalled the same batch of medication under the Benylin Paediatric brand.
Nigeria's health regulator said laboratory tests on the syrup showed a high level of diethylene glycol, which has been linked to the deaths of dozens of children in Gambia, Uzbekistan and Cameroon since 2022 in one of the world's worst waves of poisoning from oral medication.
Kenya's Pharmacy and Poisons Board (PPB) said in a statement it had commenced investigations and advised that sales of certain batches of the product be halted and returned to suppliers.
Kenvue (KVUE.N), which now owns the Benylin brand after a spin-off from J&J last year, did not immediately respond to a request for comment.
The batch being recalled was made by J&J in South Africa in May 2021 with an expiration date of April 2024, PPD said.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter.Reuters

Nigeria Acts Over Students Told To Leave UK
NHIA To Implement 6 month Dialysis Support From June 1 NHIA Boss Assures Ghanaians
TbDEX Africa To Hold Workshop in Africa Following Partnership with Chipper Cash
Make Dec 7 NPPs Day NAPO Tells Residents In Ashanti Region
Empowerment Worship Centre Kicks off Stand in the Gap 2024 Conference
QNET Marks 26 Years Of Unstoppable Impact At VCON 2024
Democracy Hub Protesters Arrest Youll Be Remembered For This On December 7 Joyce Bawah Blasts Govt